# Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation

Study · id `cardio:ct-nct06604611` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06604611](<https://clinicaltrials.gov/study/NCT06604611>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06604611

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT06604611. Randomized; no masking; primary purpose treatment. Start 2024-10-31 (anticipated); primary completion 2025-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT06604611, source copy `cardio:ctgov-nct06604611-2024-09-19`, retrieved 2026-10-26)
- Planned start: 2024-10-31 (anticipated) (ClinicalTrials.gov record NCT06604611, source copy `cardio:ctgov-nct06604611-2024-09-19`, retrieved 2026-10-26)
- Primary completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT06604611, source copy `cardio:ctgov-nct06604611-2024-09-19`, retrieved 2026-10-26)
- Completion: 2026-03-31 (anticipated) (ClinicalTrials.gov record NCT06604611, source copy `cardio:ctgov-nct06604611-2024-09-19`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06604611, source copy `cardio:ctgov-nct06604611-2024-09-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06604611-2024-09-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation
- Acronym: CHIPS
- Condition: Heart Failure
- Condition: Heart Failure With Preserved Ejection Fraction (HFPEF)
- Condition: Chronic Inflammation
- Condition: Inflammation
- Condition: Colchicine
- Intervention (Drug): Colchicine 0.5 MG Oral Tablet Once Daily
- Lead sponsor: Dongying Zhang
- Lead sponsor class: OTHER
- Collaborator: National Natural Science Foundation of China
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition term reads as this condition, and the trial is coded with its broader condition: Heart failure with mildly reduced or preserved ejection fraction (`cardio:hfpef`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Colchicine (`cardio:colchicine`)
- Registry lists this organization as a collaborator: National Natural Science Foundation of China (`cardio:org-national-natural-science-foundation-of-china`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Colchicine in acutely decompensated heart failure: the COLICA trial (`cardio:pubmed-39211951`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 2913e426cd4340056df5d98db6cd9b9c7a4874f996d5d8aa6753f9e9f0b81de1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
